Table 2 Significance (p value) of the fatty acids and lipid indexes of the early-stage breast cancer (BC) patients of this study compared among BMI groups [normal weight, NW (BMI = 18.5–24.9) n = 26; overweight, OW (BMI = 25–29.9) n = 11; obese, OB (BMI = 30–39.9) n = 13] and to the healthy normal weight control group (Healthy, n = 41)
Fatty acids and Indexes | BC NW vs Healthy p value | BC OW vs Healthy p value | BC OB vs Healthy p value | BC OB vs BC NW p value |
|---|---|---|---|---|
C16:0 palmitic acid | 0.0010 | - | - | 0.011 |
9c-C16:1 palmitoleic acid | 0.0068 | - | - | - |
C18:0 stearic acid | 0.0017 | 0.014 | - | - |
C20:3 omega-6 (dihomo-gamma linolenic acid) | - | 0.002 | - | - |
C20:4 omega-6 (arachidonic acid) | 0.0002 | 0.025 | 0.0093 | - |
C20:5 omega-3 (eicosapentaenoic acid) | 0.02 | - | - | - |
SFA | ≤0.0001 | 0.0049 | - | 0.0038 |
PUFA | ≤0.0001 | 0.03 | - | 0.023 |
PUFA omega-6 | 0.0002 | 0.02 | - | - |
SFA/MUFA | 0.05 | - | - | - |
Saturation index (b) | 0.03 | - | - | - |
Delta-6desaturase+elo index | - | - | 0.03 | - |
Unsaturation index UI | ≤0.0001 | - | - | 0.04 |
Peroxidation index PI | 0.004 | - | - | - |
